Additionally, the 36-month beta value for APVO is 5.24. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for APVO is 1.46M and currently, short sellers hold a 1.61% ratio of that float. The average trading volume of APVO on March 04, 2025 was 201.93K shares.
APVO) stock’s latest price update
Aptevo Therapeutics Inc (NASDAQ: APVO)’s stock price has decreased by -19.11 compared to its previous closing price of 3.82. However, the company has seen a -3.74% decrease in its stock price over the last five trading sessions. accessnewswire.com reported 2025-02-15 that Marvin White, President and CEO, Talks Clinical Progress, Innovation and Long-Term Growth ORLANDO, FL / ACCESS Newswire / February 15, 2025 / RedChip Companies announced today that an interview with Aptevo Therapeutics’ (Nasdaq:APVO) President and CEO Marvin White, will air on RedChip’s Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, Saturday, February 15, at 7 p.m. Eastern Time (ET).
APVO’s Market Performance
Aptevo Therapeutics Inc (APVO) has experienced a -3.74% fall in stock performance for the past week, with a -30.72% drop in the past month, and a -75.14% drop in the past quarter. The volatility ratio for the week is 12.84%, and the volatility levels for the past 30 days are at 10.23% for APVO. The simple moving average for the past 20 days is -15.52% for APVO’s stock, with a -73.49% simple moving average for the past 200 days.
Analysts’ Opinion of APVO
Piper Jaffray, on the other hand, stated in their research note that they expect to see APVO reach a price target of $6. The rating they have provided for APVO stocks is “Overweight” according to the report published on October 05th, 2017.
APVO Trading at -26.93% from the 50-Day Moving Average
After a stumble in the market that brought APVO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.23% of loss for the given period.
Volatility was left at 10.23%, however, over the last 30 days, the volatility rate increased by 12.84%, as shares sank -29.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -20.36% lower at present.
During the last 5 trading sessions, APVO fell by -3.74%, which changed the moving average for the period of 200-days by -89.72% in comparison to the 20-day moving average, which settled at $3.66. In addition, Aptevo Therapeutics Inc saw -28.31% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for APVO
The total capital return value is set at -2.62. Equity return is now at value -284.28, with -119.36 for asset returns.
Based on Aptevo Therapeutics Inc (APVO), the company’s capital structure generated 0.49 points at debt to capital in total, while cash flow to debt ratio is standing at -5.14.
Currently, EBITDA for the company is -24.6 million with net debt to EBITDA at 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.72.
Conclusion
In conclusion, Aptevo Therapeutics Inc (APVO) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
